Secretion of alpha-hemolysin by escherichia coli disrupts tight junctions in ulcerative colitis patients

Clinical and Translational Gastroenterology

Volumn 7, Issue 3, 2016, Pages E149-

  Mirsepasi Lauridsen, Hengameh Chloé ^a,b   Du, Zhengyu ^c   Struve, Carsten ^a   Charbon, Godefroid ^b   Karczewski, Jurgen ^c   Krogfelt, Karen Angeliki ^a   Petersen, Andreas Munk ^a,d   Wells, Jerry M ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; AZATHIOPRINE; CELL NUCLEUS DNA; COMPLEMENTARY DNA; CYTOTOXIC NECROTIZING FACTOR 1; MESALAZINE; OCCLUDIN; PREDNISOLONE; RNA;

ADULT; AGED; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CACO-2 CELL LINE; CELL DIFFERENTIATION; CELL VIABILITY; CLINICAL ARTICLE; CLOSTRIDIOIDES DIFFICILE; CNF1 GENE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; ELECTRIC RESISTANCE; ESCHERICHIA COLI; FECES CULTURE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; HLYA GENE; HLYI GENE; HLYII GENE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; NONHUMAN; PATHOPHYSIOLOGY; PHYLOGENY; PROTEIN DEPLETION; PROTEIN EXPRESSION; RPOA GENE; SIGMOIDOSCOPY; TIGHT JUNCTION; TRANSEPITHELIAL ELECTRIC RESISTANCE; ULCERATIVE COLITIS;

EID: 84989822712     PISSN: 2155384X     EISSN: None     Source Type: Journal    
DOI: 10.1038/ctg.2016.3     Document Type: Article

References (39)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641 1657.
2. Loftus CG, Loftus EV Jr., Harmsen WS et al. Update on the incidence and prevalence of Crohn s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254 261.
3. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46 54.e42; quiz e30.
4. Annese V, Latiano A, Andriulli A. Genetics of inflammatory bowel disease: The beginning of the end or the end of the beginning? Dig Liver Dis 2003; 35: 442 449.
5. Tysk C, Lindberg E, Jarnerot G et al. Ulcerative colitis and Crohn s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990 996.
6. Manichanh C, Borruel N, Casellas F et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9: 599 608.
7. Winter SE, Winter MG, Xavier MN et al. Host-drived nitrate boosts growth of E. coli in the inflamed gut. Science 2013; 339: 708 711.
8. Barnich N, Carvalho FA, Glasser A-L et al. CEACAM6 acts as a receptor for adherentinvasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117: 1566 1574.
9. Boudeau J, Glasser AL, Masseret E et al. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn s disease. Infect Immun 1999; 67: 4499 4509.
10. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: A putative new E. coli pathotype associated with Crohn s disease. Int J Med Microbiol 2002; 292: 185 193.
11. Kotlowski R, Bernstein CN, Sepehri S et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007; 56: 669 675.
12. Petersen AM, Nielsen EM, Litrup E et al. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol 2009; 9: 171.
13. Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 2007; 4: 134 163.
14. Böcker R, Schulz E, Gönzel D et al. α-Haemolysin of Escherichia coli in IBD: A potentiator of inflammatory activity in the colon. Gut 2014; 63: 1893 1901.
15. Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3 11.
16. Munkholm P, Langholz E, Nielsen OH et al. Incidence and prevalence of Crohn s disease in the county of Copenhagen, 1962-87: A sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609 614.
17. Miquel S, Peyretaillade E, Claret L et al. Complete genome sequence of Crohn s diseaseassociated adherent-invasive E. coli strain LF82. PLoS One 2010; 5: 1 16.
18. Rossi O, Karczewski J, Stolte EH et al. Vectorial secretion of interleukin-8 mediates autocrine signalling in intestinal epithelial cells via apically located CXCR1. BMC Res Notes 2013; 6: 431.
19. Struve C, Bojer M, Krogfelt KA. Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun 2009; 77: 5016 5024.
20. Burgos Y, Beutin L. Common origin of plasmid encoded alpha-hemolysin genes in Escherichia coli. BMC Microbiol 2010; 10: 110 193.
21. Fujimitsu K, Su etsugu M, Yamaguchi Y et al. Modes of overinitiation, dnaA gene expression, and inhibition of cell division in a novel cold-sensitive hda mutant of Escherichia coli. J Bacteriol 2008; 190: 5368 5381.
22. Vejborg RM, Hancock V, Petersen AM et al. Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics 2011; 12: 316.
23. Landraud L, Gibert M, Popoff MR et al. Expression of cnf1 by Escherichia coli J96 involves a large upstream DNA region including the hlyCABD operon, and is regulated by the RfaH protein. Mol Microbiol 2003; 47: 1653 1667.
24. Yu Q-H, Yang Q. Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier. Cell Biol Int 2009; 33: 78 82.
25. Martinez-Medina M, Aldeguer X, Lopez-Siles M et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn s disease. Inflamm Bowel Dis 2009; 15: 872 882.
26. Conte MP, Schippa S, Zamboni I et al. Gut-Associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006; 55: 1760 1767.
27. Barnich N, Carvalho FA, Glasser A-L et al. CEACAM6 acts as a receptor for adherentinvasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117: 1566 1574.
28. Welch RA. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol 1991; 5: 521 528.
29. Beutin L, Prada J, Zimmermann S et al. Enterohemolysin, a new type of hemolysin produced by some strains of enteropathogenic E. coli (EPEC). Zentralbl Bakteriol Mikrobiol Hyg A 1988; 267: 576 588.
30. Rennie RP, Arbuthnott JP. Partial characterisation of Escherichia coli haemolysin. J Med Microbiol 1974; 7: 179 188.
31. Cortajarena AL, Goñi FM, Ostolaza H. Glycophorin as a receptor for Escherichia coli alphahemolysin in erythrocytes. J Biol Chem 2001; 276: 12513 12519.
32. Cavalieri SJ, Bohach GA, Snyder IS. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol Rev 1984; 48: 326 343.
33. Nougayrede JP, Homburg S, Taieb F et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006; 313: 848 851.
34. Cooke EM, Ewins SP. Properties of strains of Escherichia coli isolated from a variety of sources. J Med Microbiol 1975; 8: 107 111.
35. Troeger H, Richter JF, Beutin L et al. Escherichia coli alpha-haemolysin induces focal leaks in colonic epithelium: A novel mechanism of bacterial translocation. Cell Microbiol 2007; 9: 2530 2540.
36. Hering NA, Fromm M, Schulzke J-D. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 2012; 590: 1035 1044
37. Arrieta MC, Madsen K, Doyle J et al. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009; 58: 41 48.
38. Wang SL, Wang ZR, Yang CQ. Meta-Analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med 2012; 4: 1051 1056.
39. Khan KJ, Ullman TA, Ford AC et al. Corrigendum: Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-Analysis. Am J Gastroenterol 2011; 106: 661 673.